Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
Open Access
- 1 March 2021
- journal article
- research article
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 26 (1), 60-65
- https://doi.org/10.6065/apem.2040042.021
Abstract
Congenital hyperinsulinism (CHI) is a rare glucose metabolism disorder characterized by unregulated secretion of insulin that leads to hyperinsulinemic hypoglycemia (HH). Most cases are caused by mutations in the K-ATP-channel genes ABCC8 and KCNJ11. We report 2 patients that experienced severe HH from the first day of life. Patient 1 developed midgut volvulus after initiating diazoxide and required intestinal resection. He was subsequently managed with a high-dose octreotide and glucose-enriched diet. Consistent with diffuse type CHI by 18F-dihydroxyphenylalanine positron emission tomography-computed tomography, genetic testing revealed a homozygous ABCC8 variant, c.1801G>A, p.(Va1601lle). The rare variant was previously reported to be diazoxide-responsive, and the patient responded well to diazoxide monotherapy, with clinical remission at 2 years of age. Patient 2 responded to diazoxide with spontaneous clinical remission at 15 months of age. However, an oral glucose tolerance test at 7 years of age revealed hyperinsulinism. Genetic testing revealed that the proband and several seemingly healthy family members harbored a novel, heterozygous ABCC8 variant, c.1780T>C, p.(Ser594Pro). Genetic findings identified previously unrecognized HH in the proband's mother. The proband's uncle had been diagnosed with monogenic ABCC8-diabetes and was successfully transitioned from insulin to glibenclamide therapy. We report findings of intestinal malrotation and volvulus occurring 2 days after initiation of diazoxide treatment. We also report a novel, heterozygous ABCC8 variant in a family that exhibited cases of CHI in infancy and HH and monogenic diabetes in adult members. The cases demonstrate the importance and clinical utility of genetic analyses for informing and guiding treatment and care.This publication has 19 references indexed in Scilit:
- Molecular mechanisms of congenital hyperinsulinismJournal of Molecular Endocrinology, 2015
- Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutationsActa Endocrinologica, 2014
- Congenital hyperinsulinism: current status and future perspectivesAnnals of Pediatric Endocrinology & Metabolism, 2014
- Clinical and molecular characterisation of 300 patients with congenital hyperinsulinismActa Endocrinologica, 2013
- Hyperinsulinaemic Hypoglycaemia: Genetic Mechanisms, Diagnosis and ManagementJournal of Clinical Research in Pediatric Endocrinology, 2012
- Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutationsDiabetologia, 2011
- Genetics of congenital hyperinsulinemic hypoglycemiaSeminars in Pediatric Surgery, 2011
- ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinismJournal of Medical Genetics, 2010
- Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutationPediatric Diabetes, 2009
- Disorders of intestinal rotation and fixation (?malrotation?)Pediatric Radiology, 2004